Company intelligence / Profile preview
Sichuan Enray Pharmaceutical Sciences Company
Chengdu, Sichuan, Chinaenraypharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Currently conducting a Phase I clinical trial for Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in patients with advanced solid tumors. The trial aims to evaluate safety, tolerability, pharmacokinetics, and preliminary efficacy of intratumoral injection of CNSI-Fe(II)[3][8].
- Therapeutic areas
- Oncology
- Modalities
- Carbon nanoparticlesCarbon Nanoparticle-Loaded Iron [CNSI-Fe(II)]
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Beyond the preview
Go deeper on Sichuan Enray Pharmaceutical Sciences Company.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sichuan Enray Pharmaceutical Sciences Company.